Stocks ZGN Financial statements
Financial statementsErmenegildo Zegna N.V. financial statements
Income statement, balance sheet and cash flow statement for the last 7 fiscal years, taken from the XBRL data Ermenegildo Zegna N.V. files with the SEC in its annual reports.
In EUR millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 1,321 | 1,015 | 1,292 | 1,493 | 1,905 | 1,947 | 1,917 |
| Cost of revenue | 496 | 565 | 680 | 650 | 623 | ||
| Gross profit | 797 | 928 | 1,224 | 1,297 | 1,294 | ||
| Selling, general and administrative | 823 | 695 | 901 | 1,008 | 1,034 | ||
| Operating income | 88.6 | -22.6 | -94 | 148 | 208 | 167 | 139 |
| Interest expense | 37.5 | 48.1 | 43.8 | 54.3 | 68.1 | 52 | 50.5 |
| Interest income | 22.1 | 34.4 | 45.9 | 13.3 | 37.3 | 26 | 41.5 |
| Pre-tax income | 69.2 | -31.6 | -97 | 101 | 169 | 131 | 140 |
| Income tax | 43.8 | 15 | 30.7 | 35.8 | 33.4 | 39.7 | 30.6 |
| Net income to minority interests | 3.69 | 4.04 | 8.34 | 13.8 | 14.1 | 13.8 | 10.9 |
| Net income | 21.7 | -50.6 | -136 | 51.5 | 122 | 77.1 | 98.6 |
| EBITDA | 257 | 144 | 60.6 | 320 | 401 | 392 | 384 |
| EPS, basic | 0.11 | -0.25 | -0.67 | 0.22 | 0.49 | 0.31 | 0.38 |
| EPS, diluted | 0.11 | -0.25 | -0.67 | 0.21 | 0.48 | 0.30 | 0.38 |
Balance sheet
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Cash and equivalents | 211 | 317 | 460 | 254 | 296 | 219 | 220 |
| Receivables | 139 | 160 | 177 | 240 | 249 | 227 | |
| Inventory | 321 | 338 | 411 | 523 | 521 | 507 | |
| Total current assets | 1,239 | 1,385 | 1,286 | 1,288 | 1,206 | 1,190 | |
| Property, plant and equipment | 244 | 111 | 126 | 160 | 205 | 211 | |
| Lease right-of-use assets | 459 | 352 | 370 | 376 | 534 | 581 | 652 |
| Goodwill | 420 | 388 | 425 | 456 | 572 | 614 | 554 |
| Total assets | 2,415 | 2,458 | 2,427 | 2,767 | 2,834 | 2,835 | |
| Accounts payable | 188 | 223 | 271 | 314 | 310 | 326 | |
| Total current liabilities | 535 | 702 | 867 | 1,012 | 853 | 750 | |
| Lease liabilities | 315 | 331 | 332 | 471 | 519 | 591 | |
| Total liabilities | 1,770 | 1,813 | 1,694 | 1,866 | 1,851 | 1,736 | |
| Total debt | 665 | 629 | 471 | 403 | 374 | 246 | |
| Retained earnings | 893 | 499 | 528 | ||||
| Shareholders' equity | 602 | 601 | 679 | 840 | 916 | 1,031 | |
| Minority interests | 43.3 | 43.1 | 53.4 | 60.6 | 66.8 | 68.1 | |
| Total equity | 730 | 645 | 644 | 732 | 901 | 983 | 1,099 |
| Total liabilities and equity | 2,415 | 2,458 | 2,427 | 2,767 | 2,834 | 2,835 |
Cash flow statement
| FY2019 | FY2021 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | |
|---|---|---|---|---|---|---|---|
| Net income | 25.4 | -46.5 | -128 | 65.3 | 136 | 90.9 | 109 |
| Depreciation and amortization | 168 | 166 | 155 | 172 | 193 | 225 | 245 |
| Cash from operations | 174 | 70.9 | 281 | 146 | 275 | 279 | 336 |
| Capital expenditures | -46.1 | -27.6 | -79.7 | -49.1 | -57 | -100 | -80.5 |
| Cash from investing | 84 | 92.6 | -82 | -57.3 | 21.8 | -126 | -110 |
| Debt issued | 131 | 265 | 124 | 0 | 204 | 260 | 49.9 |
| Debt repaid | -273 | -221 | -160 | -160 | -306 | -291 | -179 |
| Stock issued | 0 | 0 | 311 | 0 | 0 | ||
| Share buybacks | 0 | 0 | -455 | 0 | 0 | ||
| Dividends paid | -14.9 | -1.73 | -0.65 | -26 | -25 | -30.3 | -30.5 |
| Cash from financing | -267 | -49.1 | -64.1 | -297 | -250 | -235 | -215 |
| Exchange rate effect | 1.7 | -7.76 | 7.45 | 2.46 | -4.72 | 4.27 | -9.6 |
| Net change in cash | -7.71 | 107 | 143 | -205 | 42 | -77.1 | 0.99 |
| Free cash flow | 128 | 43.3 | 201 | 97.3 | 218 | 179 | 255 |
| Interest paid | 26.9 | 21 | 17.5 | 24.9 | 29.2 | 38.1 | 39.6 |
| Income taxes paid | 30.9 | 36.4 | 63.3 | 49.3 | 54 | 52.8 | 37.5 |
Key metrics
Profitability
| Metric | Value | How it is calculated |
|---|---|---|
| Gross margin | 67.5% | Gross profit / revenue. |
| Operating margin | 7.3% | Operating income / revenue. |
| EBITDA margin | 20.1% | EBITDA (operating income + depreciation and amortization) / revenue. |
| Pre-tax margin | 7.3% | Pre-tax income / revenue. |
| Net margin | 5.1% | Net income / revenue. |
| FCF margin | 13.3% | Free cash flow (cash from operations - capital expenditures) / revenue. |
| Operating cash flow margin | 17.5% | Cash from operations / revenue. |
| Effective tax rate | 21.8% | Income tax / pre-tax income, when pre-tax income is positive. |
| Return on equity (ROE) | 10.1% | Net income / average shareholders' equity (opening and closing). Not shown when equity is negative. |
| Return on assets (ROA) | 3.5% | Net income / average total assets. |
| Return on invested capital (ROIC) | 10.3% | Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%. |
| SG&A / revenue | 53.9% | Selling, general and administrative expense / revenue. |
| Capex / revenue | 4.2% | Capital expenditures / revenue. |
| D&A / revenue | 12.8% | Depreciation and amortization / revenue. |
Growth
| Metric | Value | How it is calculated |
|---|---|---|
| Revenue growth, 1y | -1.5% | Revenue vs the same period a year earlier. Only from a positive base. |
| Revenue CAGR, 3y | 8.7% | Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Revenue CAGR, 5y | 13.6% | Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Gross profit growth, 1y | -0.2% | Gross profit vs the same period a year earlier. Only from a positive base. |
| Gross profit CAGR, 3y | 11.7% | Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating income growth, 1y | -16.4% | Operating income vs the same period a year earlier. Only from a positive base. |
| Operating income CAGR, 3y | -1.9% | Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA growth, 1y | -1.8% | EBITDA vs the same period a year earlier. Only from a positive base. |
| EBITDA CAGR, 3y | 6.3% | Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EBITDA CAGR, 5y | 21.8% | Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Net income growth, 1y | 27.9% | Net income vs the same period a year earlier. Only from a positive base. |
| Net income CAGR, 3y | 24.2% | Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| EPS growth, 1y | 26.7% | EPS vs the same period a year earlier. Only from a positive base. |
| EPS CAGR, 3y | 21.9% | Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow growth, 1y | 20.2% | Operating cash flow vs the same period a year earlier. Only from a positive base. |
| Operating cash flow CAGR, 3y | 31.8% | Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Operating cash flow CAGR, 5y | 36.5% | Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Free cash flow growth, 1y | 42.5% | Free cash flow vs the same period a year earlier. Only from a positive base. |
| Free cash flow CAGR, 3y | 37.9% | Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Free cash flow CAGR, 5y | 42.6% | Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Book value growth, 1y | 12.5% | Book value vs the same period a year earlier. Only from a positive base. |
| Book value CAGR, 3y | 14.9% | Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Book value CAGR, 5y | 11.4% | Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
| Total assets growth, 1y | 0.0% | Total assets vs the same period a year earlier. Only from a positive base. |
| Total assets CAGR, 3y | 5.3% | Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive. |
| Total assets CAGR, 5y | 3.3% | Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive. |
Balance sheet health
| Metric | Value | How it is calculated |
|---|---|---|
| Current ratio | 1.59x | Current assets / current liabilities. |
| Quick ratio | 0.60x | (Cash + short-term investments + receivables) / current liabilities. |
| Cash ratio | 0.29x | (Cash + short-term investments) / current liabilities. |
| Debt / equity | 0.24x | Total debt / shareholders' equity. Not shown when equity is negative. |
| Debt / assets | 8.7% | Total debt / total assets. |
| Liabilities / assets | 61.2% | Total liabilities / total assets. |
| Net debt | €26.1M | Total debt - cash - short-term investments. Negative means more cash than debt. |
| Net debt / EBITDA | 0.07x | Net debt / EBITDA (twelve months), when EBITDA is positive. |
| Interest coverage | 2.76x | Operating income / interest expense. |
| Working capital | €439.8M | Current assets - current liabilities. |
| Goodwill and intangibles / assets | 19.5% | (Goodwill + intangible assets) / total assets. |
| Tangible book value | €476.9M | Shareholders' equity - goodwill - intangible assets. |
Efficiency
| Metric | Value | How it is calculated |
|---|---|---|
| Asset turnover | 0.68x | Revenue / average total assets. |
| Fixed asset turnover | 9.21x | Revenue / average property, plant and equipment. |
| Inventory turnover | 1.21x | Cost of revenue / average inventory. |
| Days inventory | 301 days | 365 x average inventory / cost of revenue. |
| Receivables turnover | 8.06x | Revenue / average receivables. |
| Days sales outstanding | 45 days | 365 x average receivables / revenue. |
| Days payables | 186 days | 365 x average accounts payable / cost of revenue. |
| Cash conversion cycle | 160 days | Days inventory + days sales outstanding - days payables. |
| FCF conversion | 258.7% | Free cash flow / net income, when net income is positive. |
| Capex / operating cash flow | 24.0% | Capital expenditures / cash from operations, when that is positive. |
Per share
| Metric | Value | How it is calculated |
|---|---|---|
| EPS, diluted | €0.38 | Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS. |
| EPS, basic | €0.38 | Net income per basic share, as reported (split-adjusted). |
| Payout ratio | 30.9% | Dividends paid / net income, when net income is positive. |
| Dividends / FCF | 12.0% | Dividends paid / free cash flow, when free cash flow is positive. |
What was Ermenegildo Zegna N.V.'s revenue in fiscal 2025?
Ermenegildo Zegna N.V. reported revenue of €1.92B for fiscal 2025, 1.5% lower than the year before.
Was Ermenegildo Zegna N.V. profitable in fiscal 2025?
Yes. Net income was €98.6M, a net margin of 5.1%.
How much free cash flow did Ermenegildo Zegna N.V. generate in fiscal 2025?
Cash from operations of €335.6M minus capital expenditures of €80.5M left free cash flow of €255.1M.